This page shows the latest Vokanamet news and features for those working in and with pharma, biotech and healthcare.
The FDA approval follows the decision by the European Commission in April this year to approval a combination of canagliflozin and metformin under the name Vokanamet.
Both these products are also available as combination treatments with metformin in versions called Vokanamet (Invokana and metformin) and Xigduo (Forxiga and metformin).
Janssen's Invokana was also granted European approval for a fixed dose combination with metformin that will be marketed as Vokanamet, putting it on an equal setting to AstraZeneca, which markets
Both these products are also available as combination treatments with metformin in versions called Vokanamet (Invokana and metformin) and Xigduo (Forxiga and metformin).
Vokanamet combines Invokana and metformin. Johnson &Johnson's diabetes portfolio continues to grow apace with the news that its combination treatment Vokanamet has been approved in the EU. ... Vokanamet combines J&J's already-available Invokana
The CHMP's positive opinion on Vokanamet puts the type 2 diabetes treatment on the path to full approval in the region within the next three months. ... The company will have to implement a pharmacovigilance plan for Vokanamet as part of any marketing
More from news
Approximately 2 fully matching, plus 5 partially matching documents found.
The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...